Skip to main content

Table 4 The effect of benzyl propylene glycoside on body weight and blood biochemical parameters

From: Prospective insight into the role of benzyl propylene glycoside as a modulator of the cGAS-STING signaling pathway in the management of nonalcoholic fatty pancreas animal model

Parameters

Groups

Sham

NAFP

HFHS-8 week

R-10

R-20

R-30

Initial body weight, g

160.5 ± 9.40

163.8 ± 10.23

162.7 ± 8.62

164.5 ± 6.83

161.7 ± 7.47

158.2 ± 7.41

Final body weight, g

221.7 ± 9.33

451.8 ± 14.44*

353.8 ± 10.23

421.8 ± 42.37

321.3 ± 31.14###a

268.2 ± 33.37###ab

TC (mg%)

117.3 ± 15.31

273.7 ± 10.57*

225.8 ± 8.04*##

246.8 ± 9.96#

206 ± 8.32###a

131.2 ± 20.81###δab

TG (mg%)

50.23 ± 5.37

208.4 ± 23.91*

143 ± 11.97*##

131 ± 27.83###

88.6 ± 13.73###δa

61.24 ± 5.76###δa

HDL-C (mg%)

58.67 ± 4.1

26 ± 4.13*

37 ± 2.76*##

42 ± 2.48###

45.8 ± 1.40###δ

50.51 ± 3.89###δa

LDL-C (mg%)

44.18 ± 11.55

206 ± 9.13*

160.8 ± 7.25*##

181.9 ± 10.68##δ

137.2 ± 14.57###δa

80.11 ± 10.59###δab

Glucose (mg%)

101.3 ± 13.9

392 ± 39.01*

279 ± 37.77*##

260 ± 28.95###

151.3 ± 7.94###δa

125.6 ± 15.56###δa

Insulin (µU/ml)

5.07 ± 1.15

17.78 ± 1.09*

15.24 ± 1.28*#

14.85 ± 1.09##

7.37 ± 1.71###δa

6.037 ± 1.26###δa

HOMA-IR

1.38 ± 0.27

17.25 ± 2.46*

10.75 ± 1.25*##

9.547 ± 1.39###

2.775 ± 0.75###δa

1.85 ± 0.36###δa

HbA1C%

4.28 ± 0.94

11.32 ± 1.51*

9.883 ± 1.22*

8.6 ± 0.74##

6.3 ± 0.6###δa

5 ± 1.19###δa

Lipase (U/L)

350 ± 56.57

3868 ± 166.7*

3613 ± 486*

3478 ± 511

946.7 ± 133.5###δa

595.5 ± 49.73###δa

Amylase (U/L)

983.7 ± 111.9

10,927 ± 1273*

9245 ± 1504*

9185 ± 1611#

2931 ± 478.9###δa

1190 ± 208.2###δab

  1. Values are mean ± SD; number = 8 rats/each group. One-way ANOVA followed by Tukey’s multiple comparison test
  2. *p < 0.001 vs Sham
  3. ###p < 0.001
  4. ##p < 0.01 and
  5. #p < 0.05 vs NAFP group
  6. δp < 0.05 vs HFHS-8 week
  7. ap < 0.05 vs R-10
  8. bp < 0.05 vs R-20